These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30272141)

  • 1. Assessing the Efficacy of Deoxycholic Acid for the Treatment of Submental Fat: A Three-Dimensional Study.
    Grow JN; Holding J; Korentager R
    Aesthet Surg J; 2019 Nov; 39(12):1400-1411. PubMed ID: 30272141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATX-101 (deoxycholic acid injection) for reduction of submental fat.
    Ascher B; Fellmann J; Monheit G
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1131-43. PubMed ID: 27457304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive approach to treatment of submental fullness.
    Shah GM; Greenberg JN; Tanzi EL; Monheit GD
    Semin Cutan Med Surg; 2017 Dec; 36(4):164-169. PubMed ID: 29224033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium Deoxycholate for Submental Contouring.
    Humphrey S; Beleznay K; Beleznay JD
    Skin Therapy Lett; 2016 Sep; 21(5):1-4. PubMed ID: 27603325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of 3-Dimensional Imaging in Submental Fat Reduction After Deoxycholic Acid Injection.
    Li MK; Mazur C; McDaniel DH; DaSilva D; Canfield D
    Dermatol Surg; 2018 Apr; 44(4):599-602. PubMed ID: 29059140
    [No Abstract]   [Full Text] [Related]  

  • 6. ATX-101 for reduction of submental fat: A phase III randomized controlled trial.
    Humphrey S; Sykes J; Kantor J; Bertucci V; Walker P; Lee DR; Lizzul PF; Gross TM; Beddingfield FC
    J Am Acad Dermatol; 2016 Oct; 75(4):788-797.e7. PubMed ID: 27430612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study.
    Rzany B; Griffiths T; Walker P; Lippert S; McDiarmid J; Havlickova B
    Br J Dermatol; 2014 Feb; 170(2):445-53. PubMed ID: 24147933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, Placebo-Controlled Phase 1/2 Study to Determine the Appropriate ATX-101 Concentration for Reduction of Submental Fat.
    Goodman GJ; Spelman LJ; Lowe N; Bowen B
    Dermatol Surg; 2021 Aug; 47(8):1065-1070. PubMed ID: 34115682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat: Results From a 12-Month Open-Label Study.
    Beer K; Weinkle SH; Cox SE; Rubin MG; Shamban A; Somogyif C
    J Drugs Dermatol; 2019 Sep; 18(9):870-877. PubMed ID: 31524342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATX-101 (Deoxycholic Acid Injection) Leads to Clinically Meaningful Improvement in Submental Fat: Final Data From CONTOUR.
    Behr K; Kavali CM; Munavalli G; Teller CF; Yoelin S; Breshears L; Sangha S
    Dermatol Surg; 2020 May; 46(5):639-645. PubMed ID: 31517654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special Issue: Deoxycholic Acid Injection Treatment for Reduction of Submental Fat.
    Carruthers J; Coleman K
    Dermatol Surg; 2016 Nov; 42 Suppl 1():S259. PubMed ID: 27787264
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and Efficacy of Bilateral Submental Cryolipolysis With Quantified 3-Dimensional Imaging of Fat Reduction and Skin Tightening.
    Bernstein EF; Bloom JD
    JAMA Facial Plast Surg; 2017 Sep; 19(5):350-357. PubMed ID: 28426847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in Jowl Fat following ATX-101 Treatment: Results from a Single-Site Study.
    Shridharani SM
    Plast Reconstr Surg; 2020 Apr; 145(4):929-935. PubMed ID: 32221205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Deoxycholic Acid for the Clinical Reduction of Excess Submental Fat in Indian Patients.
    Shome D; Khare S; Kapoor R
    J Drugs Dermatol; 2019 Mar; 18(3):266-272. PubMed ID: 30909331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Submental Deoxycholic Acid Injections on Neck Surgery.
    Lin MJ; Dubin DP; Schwarcz RM; Khorasani H
    J Drugs Dermatol; 2019 Dec; 18(12):1281. PubMed ID: 31860219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of injectable deoxycholic acid for submental fat reduction: a systematic review and meta-analysis of randomized controlled trials.
    Cunha KS; Lima F; Cardoso RM
    Expert Rev Clin Pharmacol; 2021 Mar; 14(3):383-397. PubMed ID: 33523775
    [No Abstract]   [Full Text] [Related]  

  • 17. Deoxycholic Acid: A Review in Submental Fat Contouring.
    Deeks ED
    Am J Clin Dermatol; 2016 Dec; 17(6):701-707. PubMed ID: 27785706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental Fat.
    Dayan SH; Humphrey S; Jones DH; Lizzul PF; Gross TM; Stauffer K; Beddingfield FC
    Dermatol Surg; 2016 Nov; 42 Suppl 1():S263-S270. PubMed ID: 27787266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Expanded Safe Zone for Reduction of Submental Fullness with ATX-101 Injection.
    Shridharani SM; Chandawarkar AA
    Plast Reconstr Surg; 2019 Dec; 144(6):995e-1001e. PubMed ID: 31764639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of ATX-101 as a treatment for submental fullness: A retrospective analysis of two aesthetic practices.
    Zarbafian M; Karavan M; Greene R; Fabi SG
    J Cosmet Dermatol; 2020 Jun; 19(6):1328-1332. PubMed ID: 31553141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.